Your only mesothelioma texas news source!
Click on each item to read full story.

 
House on Fire
read story
According to a theorem laid down by the late great Texas troubadour Townes Van Zandt, the world of song can be broken down most essentially into two broad categories: there’s the blues, and there’s zippety do da.
 
(Adsense Keyword) High Paying Keyword 2010
read story
*Akaun mereka yang telah berjaya dengan adsense Kali ni pakcik ingin berkongsi ngan korang semua pasal 100 keyword Top Paying for adsense bagi tahun 2010, ini memang harga keyword-keyword yang lates la cakap korang semua.. Pakcik bagi yg baik punya untuk korang tarik pendapatan dari google dengan lumayan sekali. Pakcik cari kat2 website yang kumpul [...]
 
Miles for Meso 5K Returns to Historic Downtown Alton to Raise Money for Mesothelioma Cancer Research
read story
Last year, more than 500 participants raised thousands of dollars for mesothelioma research through the inaugural Miles for Meso race in Alton, Illinois. This year’s Miles for Meso event, planned for Sept. 25, is benefitting from a groundswell of support from those excited about doing even more to fight this deadly disease.
 
Austin Lawyer Lulu Flores Selected for Hispanic National Bar Award
read story
Longtime social and political activist, Lulu Flores, of HendlerLaw, has been selected by the Hispanic National Bar Association as the National Latina Lawyer of the Year.
 
Sharon A. Haines
read story
LAMPE, Mo. - Sharon Ann Haines, daughter of Walter and Lorene (Meyer) Mount was born July 24, 1940, ...
 
Miles for Meso 5K approaching
read story
Thursday morning, Janelle Bedel walked in for an interview wearing a T-shirt, sweatpants and a big smile.
 
FDA Review of Avandia Health Risks is Welcome News for Patients, Says Hissey Kientz, LLP
read story
The law firm of Hissey Kientz, LLP wishes to commend the Food and Drug Administration for its ongoing safety review of the health risks associated with the type-2 diabetes drug Avandia. The agency is currently reviewing whether to remove Avandia from the U.S. market after an FDA advisory panel voted to place new restrictions on its use and to make revisions to the warning label that accompanies ...